Partnership is designed to pair EDERRA’s farm-to-body functional nutrition thesis with Cepham’s evidence-based manufacturing capabilities and supply-chain rigor.
EDERRA today announced it has entered into a Letter of Intent (LOI), dated March 26, 2026, with Cepham for a strategic manufacturing and production partnership designed to support EDERRA’s functional superfood product line, including its flagship formula, EMPWR+.
Under the LOI, the parties intend to negotiate definitive agreements under which Cepham would provide production and operational support to help EDERRA scale manufacturing in phases, strengthen sourcing and packaging execution, and accelerate product innovation.
The partnership represents a key milestone in EDERRA’s evolution from an emerging brand to a scalable wellness platform as demand grows for EMPWR+, its functional greens formula designed to support cellular detox and defense, gut health, cognitive performance, and longevity.
Rather than building manufacturing infrastructure internally, EDERRA is pursuing an asset-light scaling strategy by partnering with established science and manufacturing operators, a model increasingly adopted by next-generation wellness companies seeking to scale efficiently while maintaining integrity.
EDERRA’s brand is built around a farm-to-body philosophy that connects consumers more directly to ingredient sourcing and transparency. Cepham brings decades of experience in nutraceutical ingredient development, manufacturing quality systems, and global supply chain management.
“Investors today are funding execution engines, not just products,” said Vladi Delsoglio, Founder and CEO of EDERRA. “This LOI represents an important step toward building a scalable operational foundation that matches our farm-to-body promise. By aligning with Cepham’s science-first and operations-driven approach, we aim to de-risk supply, accelerate disciplined production expansion, and deploy capital more efficiently while focusing on demand generation and distribution.”
“EDERRA is building a brand that treats sourcing and transparency as a core product feature,” said Dr. Anand Swaroop, President of Cepham. “That philosophy aligns closely with our commitment to safety, science, and sustainability. We are excited to explore a partnership designed to help EDERRA scale while preserving the integrity, traceability, and quality expectations that modern consumers and sophisticated investors expect from next-generation wellness companies.”
The agreement also reflects growing investor interest in the longevity economy, functional nutrition, and preventive health sectors expected to experience sustained growth as healthcare continues to shift toward prevention and performance optimization.
As functional nutrition increasingly blurs the lines between supplements, food, and performance health, companies capable of combining brand development, scientific credibility, and operational scale may define the next decade of the category.
“This is about building a company designed to last decades, not just ride a trend,” Delsoglio added. “Execution ultimately separates brands that get attention from brands that build categories.”
